G-CSF (Filgrastim) clinical trials

A-TANGO Phase 2 Study

This study is testing new medicines (TAK-242 and G-CSF) for people with severe liver problems caused by alcohol, called Acute-on-Chronic Liver Failure (ACLF). It wants to see if this new combination is safer and works better than current treatments.